Home β€Ί Healthcare β€Ί Biotechnology β€Ί Genomic Biomarkers Market

Genomic Biomarkers Market - Strategic Insights and Forecasts (2025-2030)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

2.3. Data Validation

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Supplier

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4.  Industry Value Chain Analysis

5. GENOMIC BIOMARKERS MARKET BY TYPE

5.1. Introduction

5.2. Predictive Biomarkers

5.3. Prognostic Biomarkers

6. GENOMIC BIOMARKERS MARKET BY INDICATION 

6.1. Introduction

6.2. Oncology 

6.3. Cardiovascular diseases 

6.4. Neurological diseases 

6.5. Renal Disorders

6.6. Others 

7. GENOMIC BIOMARKERS MARKET BY END USER  

7.1. Introduction

7.2. Hospitals

7.3. Diagnostic Centers

7.4. Others 

8. GENOMIC BIOMARKERS MARKET BY GEOGRAPHY

8.1. Global Overview

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. United Arab Emirates

8.5.3. Others

8.6. Asia-Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Thailand

8.6.7. Indonesia

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Almac Group

10.2. Bio-Rad Laboratories Inc.

10.3. Eurofins Scientific 

10.4. Myriad Genetics Inc

10.5. QIAGEN

10.6. Thermo Fisher Scientific Inc 

10.7. Illumina, Inc.

10.8. REVEAL GENOMICS, S.L.

10.9. Guardant Health

10.10. Complete Genomics Incorporated

REPORT DETAILS

Report ID:KSI061617234
Published:Dec 2024
Pages:146
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us